Publication Information

{'id': 'https://openalex.org/W2411904979', 'doi': None, 'title': "[Plasma level monitoring of psychotropic drugs in children. I-Haloperidol (author's transl)].", 'display_name': "[Plasma level monitoring of psychotropic drugs in children. I-Haloperidol (author's transl)].", 'publication_year': 1982, 'publication_date': '1982-06-19', 'ids': {'openalex': 'https://openalex.org/W2411904979', 'mag': '2411904979', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/7110982'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/7110982', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5076100566', 'display_name': 'Michel J. Dugas', 'orcid': 'https://orcid.org/0000-0003-2615-1782'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Dugas M', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006612081', 'display_name': 'E Zarifian', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Zarifian E', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067249467', 'display_name': 'Le Heuzey Mf', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Le Heuzey Mf', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090082275', 'display_name': 'N Regnier', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Regnier N', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047747226', 'display_name': 'Geneviève Durand', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Durand G', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022289121', 'display_name': 'G. Bianchetti', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Bianchetti G', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5023879534', 'display_name': 'Morselli Pl', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Morselli Pl', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 54}, 'biblio': {'volume': '11', 'issue': '29', 'first_page': '2201', 'last_page': '4'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12547', 'display_name': 'Developmental Pharmacology in Pediatric Drug Use', 'score': 0.9024, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12547', 'display_name': 'Developmental Pharmacology in Pediatric Drug Use', 'score': 0.9024, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/plasma-levels', 'display_name': 'Plasma levels', 'score': 0.61805713}, {'id': 'https://openalex.org/keywords/medication-adherence', 'display_name': 'Medication Adherence', 'score': 0.496435}], 'concepts': [{'id': 'https://openalex.org/C2780948584', 'wikidata': 'https://www.wikidata.org/wiki/Q251347', 'display_name': 'Haloperidol', 'level': 3, 'score': 0.9214364}, {'id': 'https://openalex.org/C3020079912', 'wikidata': 'https://www.wikidata.org/wiki/Q3918988', 'display_name': 'Plasma concentration', 'level': 2, 'score': 0.68459505}, {'id': 'https://openalex.org/C3017575891', 'wikidata': 'https://www.wikidata.org/wiki/Q3918988', 'display_name': 'Plasma levels', 'level': 2, 'score': 0.61805713}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5008118}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.42488778}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.41249228}, {'id': 'https://openalex.org/C15744967', 'wikidata': 'https://www.wikidata.org/wiki/Q9418', 'display_name': 'Psychology', 'level': 0, 'score': 0.34712765}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.32476997}, {'id': 'https://openalex.org/C513476851', 'wikidata': 'https://www.wikidata.org/wiki/Q170304', 'display_name': 'Dopamine', 'level': 2, 'score': 0.08843693}], 'mesh': [{'descriptor_ui': 'D006220', 'descriptor_name': 'Haloperidol', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000375', 'descriptor_name': 'Aging', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002648', 'descriptor_name': 'Child', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006220', 'descriptor_name': 'Haloperidol', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006220', 'descriptor_name': 'Haloperidol', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/7110982', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.79, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2185163944', 'https://openalex.org/W2168692948', 'https://openalex.org/W2109005336', 'https://openalex.org/W2092942380', 'https://openalex.org/W2080065035', 'https://openalex.org/W2073807744', 'https://openalex.org/W2067598545', 'https://openalex.org/W2039477324', 'https://openalex.org/W2006494840', 'https://openalex.org/W2002769258'], 'abstract_inverted_index': {'Monitoring': [0], 'of': [1, 58, 113], 'haloperidol': [2, 22], 'plasma': [3, 23, 92, 111], 'levels': [4, 24, 93], 'during': [5], 'long-term': [6], 'treatment': [7], 'is': [8], 'not': [9], 'commonly': [10], 'practised': [11], 'in': [12, 17, 27, 118, 129], 'adults': [13], 'and': [14, 29, 56, 81], 'even': [15], 'less': [16, 74, 95], 'children.': [18], 'In': [19, 68], 'this': [20], 'study,': [21], 'were': [25, 47, 62], 'measured': [26], 'children': [28], 'teenagers': [30], 'with': [31, 64, 110, 120, 131], 'psychotic': [32, 132], 'episodes': [33], 'or': [34], 'abnormal': [35, 121], 'movements.': [36], 'Steady': [37], 'state': [38], 'concentrations': [39, 112], 'ranged': [40], 'from': [41], '0.7': [42], 'to': [43, 50, 60, 87, 91, 115], '19': [44], 'ng/ml.': [45, 105], 'They': [46], 'apparently': [48], 'unrelated': [49], 'the': [51, 65], 'doses': [52], 'administered': [53], '(15-285': [54], 'micrograms/kg/day),': [55], 'variations': [57], 'up': [59], '15-fold': [61], 'observed': [63, 109], 'same': [66], 'dosage.': [67], 'contrast,': [69], 'a': [70], 'significant': [71], 'correlation': [72], '(p': [73, 94], 'than': [75, 96, 103], '0.02)': [76], 'was': [77, 108, 127], 'determined': [78], 'between': [79], 'age': [80], 'dose-concentration': [82], 'ratio.': [83], 'Side-effects': [84], 'also': [85], 'seemed': [86], 'be': [88], 'significantly': [89], 'related': [90], '0.01);': [97], 'they': [98], 'occurred': [99], 'at': [100], 'concentration': [101], 'higher': [102], '6': [104], 'Therapeutic': [106], 'response': [107], '1': [114], '4': [116], 'ng/ml': [117], 'cases': [119], 'movements,': [122], 'but': [123], 'no': [124], 'dose-effect': [125], 'relationship': [126], 'found': [128], 'patients': [130], 'episodes.': [133]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2411904979', 'counts_by_year': [], 'updated_date': '2024-09-18T07:39:48.817796', 'created_date': '2016-06-24'}